Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug discovery in focal and segmental glomerulosclerosis.

Kidney international - 1 Jun 2016

Pullen Nick, Fornoni Alessia

Abstract excerpt

Despite the high medical burden experienced by patients with focal segmental glomerulosclerosis, the etiology of the condition remains largely unknown. Focal segmental glomerulosclerosis is highly heterogeneous in clinical and morphologic manifestations. While this presents challenges for the development of new treatments, research investments over the last 2 decades have yielded a surfeit of potential avenues...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Drug Discovery
Share to Glomerular Filtration Rate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glomerulosclerosis, Focal Segmental

Share to Kidney Glomerulus

Share to Podocytes

Share to Proteinuria

Share to Translational Research, Biomedical

Source

Open in PubMed Open full text

Identifiers

PMID: 27165834
DOI: 10.1016/j.kint.2015.12.058
PMCID: PMC4875964

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug discovery in focal and segmental glomerulosclerosis.PMID 27165834Read ↗

Towards a biological characterization of focal segmental glomerulosclerosis.Semantic proximity Read ↗

Pathogenesis and therapy of focal segmental glomerulosclerosis: an update.Semantic proximity Read ↗

[Focal segmental glomerulosclerosis (FSGS). Molecular defects and clinical relevance].Semantic proximity Read ↗

Monogenic focal segmental glomerulosclerosis: A conceptual framework for identification and management of a heterogeneous diseaseSemantic proximity Read ↗

A Review of Focal Segmental Glomerulosclerosis Classification With a Focus on Genetic AssociationsSemantic proximity Read ↗

Mechanisms of disease: focal segmental glomerulosclerosis.Semantic proximity Read ↗

Framework for precision medicine in focal segmental glomerulosclerosis: Translation of sparsentan-responsive genes in a rat model to kidney disease associated proteins in biofluidsSemantic proximity Read ↗

Pathobiology of focal segmental glomerulosclerosis: new developments.Semantic proximity Read ↗

Protecting Podocytes: A Key Target for Therapy of Focal Segmental Glomerulosclerosis.Semantic proximity Read ↗

Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosisSemantic proximity Read ↗

Pathogenesis of focal and segmental glomerulosclerosis: a review.Semantic proximity Read ↗

Clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adultsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.